M&T Bank
PCVX icon

M&T Bank’s Vaxcyte PCVX Stock Holding History

M&T Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$332K Buy
5,835
+1,560
+36% +$90.9K ﹤0.01% 1410
2026
Q2 		$248K Buy
4,275
+35
+0.8% +$1.9K ﹤0.01% 1553
2026
Q1 		$246K Buy
+4,240
New +$230K ﹤0.01% 1476

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

M&T Bank's PCVX Position: Q3 2026 in Review

M&T Bank increased its Vaxcyte (PCVX) stake by 36% in Q3 2026, buying an estimated $90.9K and bringing the position to 5,835 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1410.

M&T Bank first reported a position in PCVX in Q1 2026 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • M&T Bank held 5,835 shares of Vaxcyte worth $332K as of Q3 2026.
  • M&T Bank bought 1,560 Vaxcyte shares in Q3 2026, an estimated $90.9K.
  • Vaxcyte made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1410 holding.
  • M&T Bank first reported a position in Vaxcyte in Q1 2026 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.